Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes.
Ify R MordiAaron TeeColin N PalmerRory J McCrimmonAlexander S F DoneyChim C LangPublished in: ESC heart failure (2020)
Individuals with T2D and with MiVD are at risk of incident HF independent of a history of prior HF or MI. Patients with MiVD could benefit from screening for HF and individualized therapy with treatments that lower HF risk.
Keyphrases
- acute heart failure
- ejection fraction
- heart failure
- type diabetes
- aortic stenosis
- cardiovascular disease
- left ventricular
- insulin resistance
- stem cells
- atrial fibrillation
- metabolic syndrome
- transcatheter aortic valve replacement
- skeletal muscle
- coronary artery disease
- weight loss
- aortic valve
- cardiac resynchronization therapy